This investigative research report examines the FDA’s ongoing effort to schedule 7-hydroxymitragynine (7-OH), a naturally occurring alkaloid found in kratom and produced endogenously in the human body. Drawing on pharmacological literature, expert commentary, regulatory inconsistencies, and media dynamics, we argue that the FDA’s approach reflects a deeper failure of evidence-based policy. Rather than promoting public […]